Comment on: “Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus”

被引：0

作者：

Emanuel Raschi

Elisabetta Poluzzi

Fabrizio De Ponti

机构：

[1] Alma Mater Studiorum-University of Bologna,Department of Medical and Surgical Sciences

来源：

Clinical Pharmacokinetics | 2015年 / 54卷

关键词：

Pioglitazone; Sitagliptin; Vildagliptin; Saxagliptin; Alogliptin;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：447 / 448

页数：1

共 50 条

[1] Comment on: "Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus''
Raschi, Emanuel
Poluzzi, Elisabetta
De Ponti, Fabrizio
CLINICAL PHARMACOKINETICS, 2015, 54 (04) : 447 - 448
[2] Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus
Scheen, Andre J.
CLINICAL PHARMACOKINETICS, 2014, 53 (09) : 773 - 785
[3] Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus
André J. Scheen
Clinical Pharmacokinetics, 2014, 53 : 773 - 785
[4] Erratum to: Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus
André J. Scheen
Clinical Pharmacokinetics, 2014, 53 : 1061 - 1061
[5] Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus (vol 53, pg 773, 2014)
Scheen, Andre J.
CLINICAL PHARMACOKINETICS, 2014, 53 (11) : 1061 - 1061
[6] Author’s Reply to De Ponti et al.: “Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus”
André J. Scheen
Clinical Pharmacokinetics, 2015, 54 : 449 - 451
[7] Author's Reply to De Ponti et al.: "Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus''
Scheen, Andre J.
CLINICAL PHARMACOKINETICS, 2015, 54 (04) : 449 - 451
[8] Efficacy and Safety of Incretin-Based Therapies in Patients with Type 2 Diabetes Mellitus
Gilbert, Matthew P.
Pratley, Richard E.
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2009, 20 : S309 - S318
[9] Efficacy and Safety of Incretin-Based Therapies in Patients with Type 2 Diabetes Mellitus
Gilbert, Matthew P.
Pratley, Richard E.
AMERICAN JOURNAL OF MEDICINE, 2009, 122 (06): : 11 - 24
[10] Pharmacokinetics and Clinical Use of Incretin-Based Therapies in Patients with Chronic Kidney Disease and Type 2 Diabetes
André J. Scheen
Clinical Pharmacokinetics, 2015, 54 : 1 - 21

← 1 2 3 4 5 →